557
Views
1
CrossRef citations to date
0
Altmetric
Articles

Housing Instability, Structural Vulnerability, and Non-Fatal Opioid Overdoses Among People Who Use Heroin in Washington Heights, New York City

ORCID Icon, , , , , , & show all
Pages 320-330 | Received 12 Feb 2021, Accepted 18 Apr 2021, Published online: 04 Jun 2021

References

  • Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999-2018. NCHS Data Brief. 2020;356.
  • Ngo A, Turbow D. Principal component analysis of morbidity and mortality among the United States homeless population: a systematic review and meta-analysis. Int Arch Public Health Commun Med 2019;3(2). doi:10.23937/2643-4512/1710025.
  • Baggett TP, Hwang SW, O’Connell JJ, et al. Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period. JAMA Intern Med. 2013;173(3):189–195. doi:10.1001/jamainternmed.2013.1604.
  • Henry M, Mahathey A, Morrill T, et al. The 2018 Annual Homeless Assessment Report (AHAR) to Congress. US Department of Housing and Urban Development. https://www.hudexchange.info/resource/5783/2018-ahar-part-1-pit-estimates-of-homelessness-in-the-us/. Published December, 2018. Accessed May 12, 2021.
  • US Department of Housing and Urban Development. 2019 Continuums of Care homeless populations and subpopulations rports: New York City. https://files.hudexchange.info/reports/published/CoC_PopSub_State_NY_2019.pdf. Published September, 2019. Accessed May 12, 2021.
  • Paone D, Nolan M, Tuazon E, Blachman-Forshay J. Unintentional drug poisoning (overdose) deaths in New York City, 2000–2016. Epi Data Brief. 2017;89.
  • Chatterjee D, Krampner J, Shin J, et al. New York City Government Poverty Measure 2017: An annual Report from the Office of the Mayor. https://www1.nyc.gov/assets/opportunity/pdf/19_poverty_measure_report.pdf. Published April 2019. Accessed May 12, 2021.
  • US Census Bureau. American Community Survey 1-year estimates from Census Reporter Profile page for NYC-Manhattan Community District 12–Washington Heights, Inwood & Marble Hill PUMA, NY. http://censusreporter.org/profiles/79500US3603801-nyc-manhattan-community-district-12-washington-heights-inwood-marble-hill-puma-ny/. Published 2019. Accessed May 12, 2021.
  • James K, Jordan A. The opioid crisis in black communities. J Law Med Ethics. 2018;46(2):404–421. doi:10.1177/1073110518782949.
  • Hedegaard H. Drug Overdose Deaths in the United States, 1999-2015. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2017.
  • Ashton CM, Haidet P, Paterniti DA, et al. Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?J Gen Intern Med. 2003;18(2):146–152. doi:10.1046/j.1525-1497.2003.20532.x.
  • Bourgois P, Hart LK. Commentary on Genberg et al. (2011): the structural vulnerability imposed by hypersegregated US inner-city neighborhoods-a theoretical and practical challenge for substance abuse research. Addiction. 2011;106(11):1975–1977. doi:10.1111/j.1360-0443.2011.03615.x.
  • Holmes SM. Structural vulnerability and hierarchies of ethnicity and citizenship on the farm. Med Anthropol. 2011;30(4):425–449. doi:10.1080/01459740.2011.576728.
  • Bourgois P, Holmes S, Sue K, Quesada J. Structural vulnerability: operationalizing the concept to address health disparities in clinical care. Acad Med. 2017;92(3):299–307. doi:10.1097/ACM.0000000000001294.
  • Bartholomew TS, Tookes HE, Bullock C, Onugha J, Forrest DW, Feaster DJ. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: a latent class analysis. Int J Drug Policy. 2020;78. doi:10.1016/j.drugpo.2020.102716.
  • Buresh M, Gicquelais RE, Astemborski J, Kirk GD, Mehta SH, Genberg BL. Fatal overdose prevention and experience with naloxone: a cross-sectional study from a community-based cohort of people who inject drugs in Baltimore, Maryland. PLoS One. 2020;15(3):e0230127. doi:10.1371/journal.pone.0230127.
  • Rafful C, Orozco R, Rangel G, et al. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. 2018;113(6):1056–1063. doi:10.1111/add.14159.
  • Carlson RG, Nahhas RW, Martins SS, Daniulaityte R. Predictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history study. Drug Alcohol Depend. 2016;160:127–134. doi:10.1016/j.drugalcdep.2015.12.026.
  • Cerdá M, Santaella J, Marshall BDL, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167(3):605–612. doi:10.1016/j.jpeds.2015.04.071.
  • Guarino H, Mateu-Gelabert P, Teubl J, Goodbody E. Young adults’ opioid use trajectories: from nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose. Addict Behav. 2018;86:118–123. doi:10.1016/j.addbeh.2018.04.017.
  • Kerr T, Marshall BDL, Miller C, et al. Injection drug use among street-involved youth in a Canadian ­setting. BMC Public Health. 2009;9(1):171–171. doi:10.1186/1471-2458-9-171.
  • Silva K, Schrager SM, Kecojevic A, Lankenau SE. Factors associated with history of non-fatal overdose among young nonmedical users of prescription drugs. Drug Alcohol Depend. 2013;128(1-2):104–110. doi:10.1016/j.drugalcdep.2012.08.014.
  • Altekruse SF, Cosgrove CM, Altekruse WC, Jenkins RA, Blanco C. Socioeconomic risk factors for fatal opioid overdoses in the United States: findings from the mortality disparities in American communities study (MDAC). PLoS One. 2020;15(1):e0227966. doi:10.1371/journal.pone.0227966.
  • Nettle D. Does hunger contribute to socioeconomic gradients in behavior?Front Psychol. 2017;8:358–358. doi:10.3389/fpsyg.2017.00358.
  • Wilson N, Kariisa M, Seth P, Smith H, Davis N. Drug and opioid-involved overdose deaths - United States, 2017-2018. MMWR Morb Mortal Wkly Rep. 2020;69(11):290–297. doi:10.15585/mmwr.mm6911a4.
  • Seth P, Scholl L, Rudd R, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018;67(12):349–358. doi:10.15585/mmwr.mm6712a1.
  • Aguirre-Molina M, Gorman DM. Community-based approaches for the prevention of alcohol, tobacco, and other drug use. Annu Rev Public Health. 1996;17(1):337–358. doi:10.1146/annurev.pu.17.050196.002005.
  • Hall B. From margins to center? The development and purpose of participatory research. Am Soc. 1992;23(4):15–28. doi:10.1007/BF02691928.
  • Israel BA, Schulz AJ, Parker EA, Becker AB. Review of community-based research: assessing partnership approaches to improve public health. Annu Rev Public Health. 1998;19(1):173–202. doi:10.1146/annurev.publhealth.19.1.173.
  • Muhib F, Lin L, Stueve A, et al. A venue-based method for sampling hard-to-reach populations. Public Health Rep. 2001;116(1_suppl):216–222. doi:10.1093/phr/116.S1.216.
  • Albanese T, Wood M, Spellman B. Housing Status Assessment Guide for State TANF and Medicaid Programs. Report to the Office of Human Services Policy, Office of the Assistant Secretary for Planning and Evaluation, and the Health Resources and Services Administration. Bethesda, MD: US Department of Health and Human Services. https://aspe.hhs.gov/system/files/pdf/75736/report.pdf. Published Winter, 2009. Accessed May 12, 2021.
  • StataCorp. Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC; 2019.
  • Israel BA. Methods for Community-Based Participatory Research for Health. 2nd ed. San Francisco: Jossey-Bass; 2005.
  • Macaulay AC, Commanda LE, Freeman WL, et al. Participatory research maximises community and lay involvement. BMJ. 1999;319(7212):774–778. doi:10.1136/bmj.319.7212.774.
  • O’Fallon L, Dearry A. Community-based participatory research as a tool to advance environmental health sciences. Environ Health Perspect. 2002;110(suppl 2):155–159. doi:10.1289/ehp.02110s2155.
  • US Office of the Assistant Secretary for Planning and Evaluation. 2019 poverty guidelines. US Office of the Assistant Secretary for Planning and Evaluation. https://aspe.hhs.gov/2019-poverty-guidelines.
  • Nolan ML, Tuazon E, Paone D. Unintentional drug poisoning (overdose) deaths in New York City in 2019. Epi Data Brief. 2020;122.
  • Darke S, Mills KL, Ross J, Teesson M. Rates and correlates of mortality amongst heroin users: Findings from the Australian Treatment Outcome Study (ATOS), 2001-2009. Drug Alcohol Depend. 2011;115(3):190–195. doi:10.1016/j.drugalcdep.2010.10.021.
  • Stoové MA, Dietze PM, Jolley D. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data. Drug Alcohol Rev. 2009;28(4):347–352. doi:10.1111/j.1465-3362.2009.00057.x.
  • Caudarella A, Dong H, Milloy MJ, Kerr T, Wood E, Hayashi K. Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug Alcohol Depend. 2016;162:51–55. doi:10.1016/j.drugalcdep.2016.02.024.
  • Pollini RA, McCall L, Mehta SH, Vlahov D, Strathdee SA. Non-fatal overdose and subsequent drug treatment among injection drug users. Drug Alcohol Depend. 2006;83(2):104–110. doi:10.1016/j.drugalcdep.2005.10.015.
  • Pollini RA, O’Toole TP, Ford D, Bigelow G. Does this patient really want treatment? Factors associated with baseline and evolving readiness for change among hospitalized substance using adults interested in treatment. Addict Behav. 2006;31(10):1904–1918. doi:10.1016/j.addbeh.2006.01.003.
  • Rhodes T. The ‘risk environment’: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94. doi:10.1016/S0955-3959(02)00007-5.
  • Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet (London, England). 2013;382(9904):1564–1574. doi:10.1016/S0140-6736(13)61530-5.
  • Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction. 1994;89(10):1299–1308. doi:10.1111/j.1360-0443.1994.tb03309.x.
  • Perucci CA, Davoli M, Rapiti E, Abeni DD, Forastiere F. Mortality of intravenous drug users in Rome: a cohort study. Am J Public Health. 1991;81(10):1307–1310. doi:10.2105/AJPH.81.10.1307.
  • Vaillant GE. A 20-year follow-up of New York narcotic addicts. Arch Gen Psychiatry. 1973;29(2):237–241. doi:10.1001/archpsyc.1973.04200020065009.
  • Darke S, Zador D. Fatal heroin ‘overdose’: a review. Addiction. 1996;91(12):1765–1772. doi:10.1111/j.1360-0443.1996.tb03800.x
  • Vlahov D, Fuller C, Ompad D, Galea S, Jarlais D. Updating the infection risk reduction hierarchy: preventing transition into injection. J Urban Health. 2004;81(1):14–19. doi:10.1093/jurban/jth083.
  • Werb D, Buxton J, Shoveller J, Richardson C, Rowell G, Wood E. Interventions to prevent the initiation of injection drug use: a systematic review. Drug Alcohol Depend. 2013;133(2):669–676. doi:10.1016/j.drugalcdep.2013.08.017.
  • Topp L, Iversen J, Baldry E, Maher L, Collaboration of Australian NSPs. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013;90(4):699–716. doi:10.1007/s11524-012-9730-6.
  • Linton SL, Celentano DD, Kirk GD, Mehta SH. The longitudinal association between homelessness, injection drug use, and injection-related risk behavior among persons with a history of injection drug use in Baltimore, MD. Drug Alcohol Depend. 2013;132(3):457–465. doi:10.1016/j.drugalcdep.2013.03.009.
  • Watson D, Shuman V, Kowalsky J, Golembiewski E, Brown M. Housing first and harm reduction: a rapid review and document analysis of the US and Canadian open-access literature. Harm Reduct J. 2017;14(1):30. doi:10.1186/s12954-017-0158-x.
  • Pouget ER, Fong C, Rosenblum A. Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005-2016. Subst Use Misuse. 2018;53(2):290–300. doi:10.1080/10826084.2017.1334070.
  • Allen B, Nolan ML, Kunins HV, Paone D. Racial differences in opioid overdose deaths in New York City, 2017. JAMA Intern Med. 2019;179(4):576–578. doi:10.1001/jamainternmed.2018.7700.
  • Kral HA, Lorvick RJ, Edlin RB. Sex- and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2000;24(2):162–167. doi:10.1097/00042560-200006010-00011.
  • Ochoa KC, Hahn JA, Seal KH, Moss AR. Overdosing among young injection drug users in San Francisco. Addict Behav. 2001;26(3):453–460. doi:10.1016/S0306-4603(00)00115-5.
  • Dowling-Guyer S, Johnson ME, Fisher DG, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–392. doi:10.1177/107319119400100407.
  • Watters JK, Needle R, Brown BS, Weatherby N, Booth R, Williams M. The self-reporting of cocaine use. JAMA. 1992;268(17):2374–2375. doi:10.1001/jama.268.17.2374.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.